We market well.
Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.
Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.
Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.
People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
recent work right here
GENEVA (Reuters) - The United Kingdom violates women's rights in Northern Ireland by unduly restricting their access to abortion, a report by the U.N. Committee on the Elimination of Discrimination against Women (CEDAW) said on Friday.... HINDHEAD, England (Reuters) - For 93-year-old Daphne Padfield, a dementia sufferer in an English care home, the arrival of a virtual reality (VR) headset offered a window back to the day in 1953 when Britain crowned its new queen.... (Reuters) - A European Medicines Agency (EMA) panel on Friday recommended against approving Puma Biotechnology's lead breast cancer drug, an outcome the U.S drugmaker had signaled last month.... (Reuters Health) - People who get minimally-invasive surgery to replace damaged heart valves have an easier time completing daily tasks and a better quality of life after the procedure, a research review suggests.... (Reuters Health) - The majority of people believe cardiopulmonary resuscitation (CPR) is successful more often than it tends to be in reality, according to a small U.S. study.... (Reuters) - KemPharm Inc said on Friday the U.S. Food and Drug Administration approved its opioid painkiller Apadaz for the short-term management of acute pain, sending the shares of the drugmaker up as much as 36 percent in late afternoon trading.... (Reuters Health) - Some diabetics with plaque buildup in their arteries might have less debris in these blood vessels after adding wine to their diets, a recent study suggests.... (Reuters Health) - Older adults who have elective surgery are more likely to experience delirium afterwards when they’re frail, a research review suggests.... (Reuters) - U.S. drugmaker Gilead Sciences Inc will use Sangamo Therapeutics Inc's gene-editing technology to develop cancer treatments in a deal potentially worth about $3 billion to Sangamo, the companies said on Thursday.... (Reuters Health) - Men who drink alcohol in late adolescence are more likely to develop severe liver disease decades later than young people who don’t drink at all, a Swedish study suggests....